Padala SA, Barsouk A, Thandra KC, Kalyan S, Mohammed A, Vakiti A, Rawla P, Barsouk A (2020) Epidemiology of renal cell carcinoma. World J Oncol 11:79–87
Article PubMed PubMed Central Google Scholar
Campbell SC, Lane BR (2012) Malignant renal tumors. Camp- bell-Walsh Urol
Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S et al (2022) European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82:399–410
Motzer RJ, Escudier B, McDermott DF, Arén Frontera O, Melichar B, Powles T et al (2020) Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42 month follow-up of a randomized phase clinical trial. J Immunother Cancer 8(2):e000891
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T et al (2021) Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. N Engl J Med 384:1289–1300
Article PubMed CAS Google Scholar
Spasic M, Zaric D, Mitrovic M, Milojevic S, Nedovic N, Sekulic M et al (2023) Secondary breast malignancy from renal cell carcinoma: challenges in diagnosis and treatment-case report. Diagnostics (Basel) 13:991
Mahuvakar AD, Nair D, Pai PS (2020) Transnasal endoscopic resection of the intraconal metastases from renal cell carcinoma: a case report and review of literature. Indian J Surg Oncol 11:318–322
Article PubMed PubMed Central Google Scholar
Mikhail M, Chua KJ, Khizir L, Tabakin A, Singer EA (2022) Role of metastasectomy in the management of renal cell carcinoma. Front Surg. 29(9):943604
Tayeh GA, Alkassis M, De La Taille A, Vordos D, Champy CM, Pelegrin T, Ingels A (2024) Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review. World J Urol 42:51
Suzuki I, Kijima T, Takada-Owada A, Nakamura G, Uematsu T, Sakamoto K, Nishihara D, Ishida K, Kamai T (2021) A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib. IJU Case Rep. 4:412–416
Article PubMed PubMed Central Google Scholar
Ell J, Balz P, Manava P, Hüttenbrink C (2023) Downstaging and pathological complete response of locally recurrent sarcomatoid renal cell carcinoma under pembrolizumab and lenvatinib: a case report and review of literature. Case Rep Oncol 16:1245–1252
Comments (0)